How much funding has Terran Psychedelics raised?

Terran Psychedelics has raised $9.4M in total funding, most recently a Seed round.

Who are Terran Psychedelics's investors?

Terran Psychedelics's investors include Able Partners.

When was Terran Psychedelics founded?

Terran Psychedelics was founded in 2019.

Where is Terran Psychedelics headquartered?

Terran Psychedelics is headquartered in United States.

What industry is Terran Psychedelics in?

Terran Psychedelics operates in Legal Tech, Mental Health, Biotech, Healthcare.

How many employees does Terran Psychedelics have?

Terran Psychedelics has 1-10 employees.

Terran Psychedelics

Psychedelic therapeutics redesigned

United States · Founded 2019 · $9.4M raised

Employees: 1–10
Founded: 2019
Business Model: B2B
Website: terranbiosciences.com

Total Funding: $9.4M
Last Round: $9.4M SeedOct 2019
Rounds: 1

About

Terran Biosciences is a biotech platform company developing transformative therapeutics for patients with neurological and psychiatric diseases. The company holds one of the largest psychedelic patent portfolios in the industry, with over 150 patents and patent applications spanning novel forms of psilocybin, MDMA, LSD, DMT, and other compounds. Its pipeline includes TerXT (a novel prodrug combination for schizophrenia) and Phase 3 selective serotonin 2A receptor antagonists licensed from Sanofi. The company also received FDA clearance for NM-101, an AI-enabled cloud-based software platform for analyzing neuromelanin MRI scans. Founded in 2019 by Dr. Samuel Clark, MD, PhD.

Summary

Terran Psychedelics is a Legal Tech company based in United States, founded in 2019. It has raised $9.4M in total across 1 round, most recently a $9.4M Seed round in Oct 2019. Investors include Able Partners.